Diabetes, sleep apnea, obesity and cardiovascular disease: Why not address them together?

Area of Science:

• Cardiology
• Endocrinology
• Pulmonology
• Sleep Medicine

Background:

• Obesity, sleep apnea, diabetes, and cardiovascular diseases impose significant global health and economic burdens.
• Current clinical practices prioritize blood pressure and BMI, often overlooking sleep-related symptoms and sleep apnea screening.
• Despite recommendations, sleep apnea screening is neglected in cardiac, diabetic, pulmonary, and general medicine settings.

Purpose of the Study:

• To highlight the central role of obesity and obstructive sleep apnea in the development of diabetes and cardiovascular complications.
• To advocate for the integration of obstructive sleep apnea screening into routine patient assessments.
• To question the current oversight of sleep apnea screening in major medical disciplines.

Main Methods:

• This editorial reviews current medical literature and clinical guidelines.
• It analyzes the interconnectedness of metabolic and cardiovascular diseases with sleep disorders.
• It discusses the implications of incorporating sleep apnea screening as a vital sign.

Main Results:

• Growing evidence links obesity and obstructive sleep apnea to diabetes and cardiovascular disease.
• Effective management of obstructive sleep apnea can prevent or improve these conditions.
• Current screening practices fail to address the prevalence and impact of sleep apnea.

Conclusions:

• Obstructive sleep apnea (OSA) is a critical, yet often overlooked, condition.
• Integrating OSA screening as a vital sign is essential for comprehensive patient care.
• Routine screening can lead to earlier diagnosis and better management of associated chronic diseases.